These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 4084537)

  • 1. Mechanism for reactivation of N-cyclopropylbenzylamine-inactivated monoamine oxidase by amines.
    Yamasaki RB; Silverman RB
    Biochemistry; 1985 Nov; 24(23):6543-50. PubMed ID: 4084537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revised mechanism for inactivation of mitochondrial monoamine oxidase by N-cyclopropylbenzylamine.
    Vazquez ML; Silverman RB
    Biochemistry; 1985 Nov; 24(23):6538-43. PubMed ID: 4084536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism-based inactivation of mitochondrial monoamine oxidase by N-(1-methylcyclopropyl)benzylamine.
    Silverman RB; Yamasaki RB
    Biochemistry; 1984 Mar; 23(6):1322-32. PubMed ID: 6712946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of alpha-methylation on inactivation of monoamine oxidase by N-cyclopropylbenzylamine.
    Silverman RB
    Biochemistry; 1984 Oct; 23(22):5206-13. PubMed ID: 6509020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-(1-Methyl)cyclopropylbenzylamine: a novel inactivator of mitochondrial monoamine oxidase.
    Silverman RB; Hoffman SJ
    Biochem Biophys Res Commun; 1981 Aug; 101(4):1396-401. PubMed ID: 7306137
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition and inactivation of monoamine oxidase by 3-amino-1-phenyl-prop-1-enes.
    Williams CH; Lawson J; Backwell FR
    Biochim Biophys Acta; 1992 Feb; 1119(2):111-7. PubMed ID: 1540641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of inactivation of monoamine oxidase by 1-phenylcyclopropylamine.
    Silverman RB; Zieske PA
    Biochemistry; 1985 Apr; 24(9):2128-38. PubMed ID: 3995007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Chloro-2-phenylethylamine as a mechanistic probe and active site-directed inhibitor of monoamine oxidase from bovine liver mitochondria.
    Weyler W
    Arch Biochem Biophys; 1987 Jun; 255(2):400-8. PubMed ID: 3592682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of monoamine oxidase by allylamine does not result in flavin attachment.
    Silverman RB; Hiebert CK; Vazquez ML
    J Biol Chem; 1985 Nov; 260(27):14648-52. PubMed ID: 4055794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of new 2-propinylamine derivatives on mitochondrial monoamine oxidase activity].
    Shatemirova KK; Davydova GA; Verevkina IV; Tichilkin AI
    Vopr Med Khim; 1977; 23(5):609-18. PubMed ID: 595495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New pyrrole inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.
    La Regina G; Silvestri R; Artico M; Lavecchia A; Novellino E; Befani O; Turini P; Agostinelli E
    J Med Chem; 2007 Mar; 50(5):922-31. PubMed ID: 17256833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformation of monoamine oxidase-B primary amine substrates into time-dependent inhibitors. Tertiary amine homologues of primary amine substrates.
    Ding CZ; Lu X; Nishimura K; Silverman RB
    J Med Chem; 1993 Jun; 36(12):1711-5. PubMed ID: 8510099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships in the oxidation of benzylamine analogues by bovine liver mitochondrial monoamine oxidase B.
    Walker MC; Edmondson DE
    Biochemistry; 1994 Jun; 33(23):7088-98. PubMed ID: 8003474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transformation of heterocyclic reversible monoamine oxidase-B inactivators into irreversible inactivators by N-methylation.
    Ding CZ; Silverman RB
    J Med Chem; 1993 Nov; 36(23):3606-10. PubMed ID: 8246228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Liver monoamine oxidase activity of the lamprey Lampetra fluviatilis. the substrate-inhibitory specificity].
    Iagodina OV; Basova IN
    Zh Evol Biokhim Fiziol; 2013; 49(1):39-43. PubMed ID: 23662480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDL 72145, an enzyme-activated irreversible inhibitor with selectivity for monoamine oxidase type B.
    Zreika M; McDonald IA; Bey P; Palfreyman MG
    J Neurochem; 1984 Aug; 43(2):448-54. PubMed ID: 6736960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SAR studies of fluorine-substituted benzylamines and substituted 2-phenylethylamines as substrates and inactivators of monoamine oxidase B.
    Silverman RB; Hawe WP
    J Enzyme Inhib; 1995; 9(3):203-15. PubMed ID: 8847600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of monoamine oxidase A by the monoamine oxidase B inactivators 1-phenylcyclopropylamine, 1-benzylcyclopropylamine, and N-cyclopropyl-alpha-methylbenzylamine.
    Silverman RB; Hiebert CK
    Biochemistry; 1988 Nov; 27(22):8448-53. PubMed ID: 3242595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in kinetics of deaminated biogenic amines in spontaneous hypertension].
    Ioffina DI; Smirnov IE; Gorkin VZ
    Vopr Med Khim; 1991; 37(1):59-63. PubMed ID: 1858344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships in the oxidation of para-substituted benzylamine analogues by recombinant human liver monoamine oxidase A.
    Miller JR; Edmondson DE
    Biochemistry; 1999 Oct; 38(41):13670-83. PubMed ID: 10521274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.